These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7738399)

  • 1. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata.
    Norris DA; Duke R; Whang K; Middleton M
    J Invest Dermatol; 1995 May; 104(5 Suppl):8S-9S. PubMed ID: 7738399
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the dermal papilla a primary target in alopecia areata?
    Randall VA; Hull SP; Nutbrown M; Calver NS; Parkin SM; Cunliffe WJ
    J Invest Dermatol; 1995 May; 104(5 Suppl):7S-8S. PubMed ID: 7738398
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
    van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J
    Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
    Hull SM; Nutbrown M; Pepall L; Thornton MJ; Randall VA; Cunliffe WJ
    J Invest Dermatol; 1991 May; 96(5):673-81. PubMed ID: 1827135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and dermal papilla function in alopecia areata.
    McDonagh AJ; Elliott KR; Messenger AG
    J Invest Dermatol; 1995 May; 104(5 Suppl):9S-10S. PubMed ID: 7738400
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    Shi Y; Wan S; Song X
    J Dermatol; 2024 May; 51(5):621-631. PubMed ID: 38605467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata.
    Abdel-Naser MB; Blume-Peytavi U; Abdel-Fatah A; Orfanos CE
    Acta Derm Venereol; 1994 Sep; 74(5):351-4. PubMed ID: 7817669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEBR rat: an animal model of human alopecia areata.
    Michie HJ; Jahoda CA; Oliver RF; Johnson BE
    Br J Dermatol; 1991 Aug; 125(2):94-100. PubMed ID: 1911310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor repertoire V beta in alopecia areata.
    Szafer F; Price VH; Oksenberg JR; Steinman L
    J Invest Dermatol; 1995 May; 104(5 Suppl):22S-24S. PubMed ID: 7738379
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata.
    Hamm H; Klemmer S; Kreuzer I; Steijlen PM; Happle R; Bröcker EB
    Arch Dermatol Res; 1988; 280(3):179-81. PubMed ID: 3377529
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata.
    Wiesner-Menzel L; Happle R
    Arch Dermatol Res; 1984; 276(5):333-4. PubMed ID: 6548356
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration.
    Khoury EL; Price VH; Greenspan JS
    J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to hair follicles in alopecia areata.
    Tobin DJ; Bystryn JC
    J Invest Dermatol; 1995 May; 104(5 Suppl):13S-14S. PubMed ID: 7738373
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell degeneration in alopecia areata. An ultrastructural study.
    Tobin DJ; Fenton DA; Kendall MD
    Am J Dermatopathol; 1991 Jun; 13(3):248-56. PubMed ID: 1867355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JMM--past and present. Invited commentary on A. Blaschko: alopecia areata and trichorrhexis.
    Paus R
    J Mol Med (Berl); 2002 Jul; 80(7):387-8. PubMed ID: 12212553
    [No Abstract]   [Full Text] [Related]  

  • 17. Corroborative evidence that alopecia areata involves the epidermis and the sebaceous glands.
    Piérard-Franchimont C; Piérard GE
    Am J Dermatopathol; 1987 Apr; 9(2):111-3. PubMed ID: 3504110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-DR by anagen hair follicles in alopecia areata.
    Messenger AG; Bleehen SS
    J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential patterns of elastic fibers in scarring and non-scarring alopecias.
    Pinkus H
    J Cutan Pathol; 1978 Jun; 5(3):93-104. PubMed ID: 79579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.